
Positive sentiment towards VNDA reflected by a fall of -2.99% in short interest
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
In a filing, Vanda Pharmaceuticals Inc revealed its Director Mitchell Stephen Ray unloaded Company’s shares for reported $32130.0 on Jun
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
In a filing, Vanda Pharmaceuticals Inc revealed its Director Mitchell Stephen Ray unloaded Company’s shares for reported $32130.0 on Jun
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
In a filing, Vanda Pharmaceuticals Inc revealed its Director Mitchell Stephen Ray unloaded Company’s shares for reported $32130.0 on Jun
Vanda Pharmaceuticals Inc’s recent filing unveils that its Director Mitchell Stephen Ray unloaded Company’s shares for reported $32130.0 on Jun
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) does about 670.95K shares in volume on a normal day but saw 493956 shares change hands